This compound is a pharmaceutical impurity reference standard of levofloxacin, specifically a nitrosamine derivative identified as (2S)-7-fluoro-2-methyl-6-(4-nitrosopiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7. 3.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1152314-62-9
Levofloxacin hemihydrate
pharmaceutical raw material
DL-ofloxacin
pharmaceutical raw material
Ofloxacin
pharmaceutical raw material
Levofloxacin
pharmaceutical raw material
(2R,3S,4S,5S)-5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexanone
pharmaceutical intermediate
Tetrabenzyl-voglibose
pharmaceutical intermediate
2-(4-Aminophenyl)-2-methylpropanenitrile
pharmaceutical intermediate
(S)-(+)-Glycidyl nosylate
pharmaceutical intermediate
(2S)-7-fluoro-2-methyl-6-(4-nitrosopiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
GNTZPZBXVIOIQQ-VIFPVBQESA-N
C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)N=O)F)C(=O)O